J. Hainfellner

D. Prayer, J. Hainfellner, G. Kasprian, 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies

E. Aronica, J. Hainfellner, A. Bongaarts, 2021, Neuropathology and applied neurobiology.

Non‐HTLV‐I associated pleomorphic T‐cell lymphoma of the brain mimicking post‐vaccinal acute inflammatory demyelination

H. Budka, J. Hainfellner, I. Simonitsch, 1997, Neuropathology and applied neurobiology.

Kuru: Genes, Cannibals and Neuropathology

J. Hainfellner, P. Liberski, P. Brown, 2012, Journal of neuropathology and experimental neurology.

Mutations of the Prion Protein Gene

H. Budka, J. Hainfellner, J. Ironside, 2002, Journal of Neurology.

Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes

H. Budka, J. Hainfellner, J. Ironside, 2002, Brain pathology.

Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie

H. Budka, J. Hainfellner, M. Beekes, 1999, Acta Neuropathologica.

Fatal familial insomnia: a new Austrian family.

K. Jellinger, H. Budka, J. Collinge, 1999, Brain : a journal of neurology.

Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions

P. Gosselaar, I. Blumcke, E. Aronica, 2021, Epilepsia.

Transgenic mice as research tools in neurocarcinogenesis.

A. Aguzzi, J. Hainfellner, T. Rülicke, 1998, Journal of neurovirology.

Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: a histopathological follow‐up

J. Hainfellner, P. Mazal, A. Gruber, 2006, Pathology.

Fluorescent In Situ Hybridization on Isolated Tumor Cell Nuclei: A Sensitive Method for 1p and 19q Deletion Analysis in Paraffin-Embedded Oligodendroglial Tumor Specimens

H. Budka, J. Hainfellner, P. Ambros, 2003, Modern Pathology.

Neocortical changes in Parkinson's disease, revisited.

H. Budka, J. Hainfellner, M. Yoshimura, 1994, Clinical neuropathology.

Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.

C. Marosi, A. Kaider, J. Hainfellner, 2013, Thrombosis research.

CASE Primary Neuroendocrine (Merkel Cell) Carcinoma of the Anterior Skull Base

C. Matula, J. Hainfellner, K. Roessler, 2006 .

Mutations of the prion protein gene phenotypic spectrum.

H. Budka, J. Hainfellner, J. Ironside, 2002, Journal of neurology.

Kynurenic acid metabolism in the brain of HIV-1 infected patients

H. Budka, J. Hainfellner, P. Mazal, 2000, Journal of Neural Transmission.

The Subplate Layers: The Superficial and Deep Subplate Can be Discriminated on 3 Tesla Human Fetal Postmortem MRI.

G. Langs, D. Prayer, C. Mitter, 2020, Cerebral cortex.

Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI

H. Budka, M. Thurnher, J. Hainfellner, 1997, Neuroradiology.

Neurite Outgrowth Inhibitor (NogoA) Is Upregulated in White Matter Lesions of Complex Cortical Malformations.

E. Aronica, J. Hainfellner, G. Kasprian, 2021, Journal of neuropathology and experimental neurology.

Dysregulation of the (immuno)proteasome pathway in malformations of cortical development

P. V. van Rijen, E. Aronica, J. Hainfellner, 2016, Journal of Neuroinflammation.

Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue.

H. Budka, J. Gerdes, J. Hainfellner, 2001, The American journal of pathology.

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

C. Marosi, G. Ricken, J. Hainfellner, 2018, Acta Neuropathologica Communications.

A novel phenotype in familial Creutzfeldt‐Jakob disease: Prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease‐resistant prion protein

H. Budka, J. Hainfellner, P. Gambetti, 1999, Annals of neurology.

Neuropathology Training Worldwide—Evolution and Comparisons

S. Powell, J. Hainfellner, M. D. Del Bigio, 2014, Brain pathology.

Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC)

E. Aronica, J. Hainfellner, P. Krsek, 2016, Journal of Molecular Neuroscience.

Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis

H. Budka, J. Hainfellner, E. Schmutzhard, 1992, Journal of neurology, neurosurgery, and psychiatry.

Intramyocardial hematoma mimicking abnormal left ventricular trabeculation.

J. Finsterer, J. Hainfellner, F. Waldenberger, 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center

J. Hainfellner, M. Preusser, R. Bartsch, 2018, Clinical & Experimental Metastasis.

Fibroblasts Can Express Glial Fibrillary Acidic Protein (GFAP) In Vivo

A. Aguzzi, H. Budka, J. Hainfellner, 2001, Journal of neuropathology and experimental neurology.

Deposition of the prion protein (PrP) during the evolution of experimental Creutzfeldt-Jakob disease

H. Budka, J. Hainfellner, P. Liberski, 1999, Acta Neuropathologica.

Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.

H. Budka, J. Hainfellner, P. Brown, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Pathology and Immunocytochemistry of a Kuru Brain

J. Hainfellner, P. Liberski, P. Brown, 1997, Brain pathology.

Echigo-1: a panencephalopathic strain of Creutzfeldt-Jakob disease. II. Ultrastructural studies in hamsters.

H. Budka, J. Hainfellner, P. Liberski, 2004, Folia neuropathologica.

Phenotypic variation in Creutzfeldt‐Jakob disease, May 31 and June 1, 1996, Vienna, Austria

H. Budka, J. Hainfellner, 1996, Brain pathology.

Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies

H. Budka, J. Hainfellner, H. Budka, 1999, Acta Neuropathologica.

Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.

D. Prayer, J. Hainfellner, S. Asenbaum, 2007, Minimally invasive neurosurgery : MIN.

Prion protein (PrP) deposits in the tectum of experimental Gerstmann-Sträussler-Scheinker disease following intraocular inoculation.

H. Budka, J. Hainfellner, P. Liberski, 2012, Folia Neuropathologica.

PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL).

G. Ricken, J. Hainfellner, M. Preusser, 2014, Clinical neuropathology.

Development of HIV encephalitis in AIDS and TNF-α regulatory elements

H. Budka, J. Hainfellner, P. Mazal, 1998, Journal of Neuroimmunology.

Malignant predominantly minigemistocytic glioma in two infants: a distinctive glioma variant?

C. Pirker, H. Budka, D. Prayer, 2007, Neuropathology and applied neurobiology.

Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology

H. Heinzl, H. Budka, J. Hainfellner, 2006, Histopathology.

Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: Implications for differential diagnosis

H. Budka, J. Hainfellner, M. Preusser, 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survival

C. Marosi, H. Budka, J. Hainfellner, 2004, Neuropathology and applied neurobiology.

Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors

H. Budka, J. Hainfellner, E. Gelpí, 2004, Acta Neuropathologica.

CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers.

M. Berger, M. Borkovec, W. Stummer, 2022, Journal of neurosurgery.

DEC1 expression in 1p-aberrant oligodendroglial neoplasms.

H. Budka, J. Hainfellner, M. Preusser, 2005, Histology and histopathology.

Expression of Hypoxia-related Tissue Factors Correlates with Diminished Survival of Adjuvantly Treated Patients with Chromosome 1p Aberrant Oligodendroglial Neoplasms and Therapeutic Implications

A. Harris, T. Acker, K. Plate, 2004, Clinical Cancer Research.

Year : 2000 Mice with combined gene knockouts reveal essential and partially redundant functions of amyloid precursor protein family members

H. Lipp, A. Aguzzi, J. Hainfellner, 2006 .

Creutzfeldt-Jakob disease in Austria.

K. Jellinger, H. Budka, J. Hainfellner, 1996, Wiener klinische Wochenschrift.

Diffuse Lewy body disease as substrate of primary lateral sclerosis

H. Budka, G. Ladurner, J. Hainfellner, 2004, Journal of Neurology.

Uncommon types of polyglucosan bodies in the human brain: distribution and relation to disease

H. Budka, J. Hainfellner, H. Lassmann, 2004, Acta Neuropathologica.

CSF and laboratory analysis (tumor markers).

J. Hainfellner, M. Preusser, 2012, Handbook of clinical neurology.

DNA topoisomerase IIα expression in optic pathway gliomas of childhood

H. Budka, M. Bredel, J. Hainfellner, 2002 .

No Complementation Between TP53 or RB‐1 and v‐src in Astrocytomas of GFAP‐v‐src Transgenic Mice

A. Aguzzi, M. Hegi, J. Hainfellner, 1999, Brain pathology.

Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria

G. Ricken, J. Hainfellner, R. Desnick, 2020, Acta Neuropathologica Communications.

Ki-67 Immunolabeling Index Is an Accurate Predictor of Outcome in Patients With Intracranial Ependymoma

H. Budka, J. Hainfellner, I. Slavc, 2004, The American journal of surgical pathology.

Clinical Neuropathology image 5-2016: neurofibrillary tangle-rich ganglioglioma

J. Hainfellner, E. Gelpí, R. Höftberger, 2016, Clinical neuropathology.

Virus production, cell proliferation and cell death in progressive multifocal leukoencephalopathy

H. Budka, J. Hainfellner, K. Sato-Matsumura, 1998 .

Teaching Case 5-2018: Integrated morphological and immunological work-up of neurosurgical specimen allows accurate diagnosis of neuroinflammatory lesions: an example of acute disseminated encephalomyelitis (ADEM) associated with anti-MOG antibodies

J. Hainfellner, E. Gelpí, A. Gruber, 2018, Clinical neuropathology.

OS07.7 Patterns of diagnostic marker assessment in adult diffuse glioma - a survey of the European Confederation of Neuropathological Societies

J. Hainfellner, B. Kristensen, A. Vital, 2017 .

Development of HIV encephalitis in AIDS and TNF-alpha regulatory elements.

H. Budka, J. Hainfellner, P. Mazal, 1998, Journal of neuroimmunology.

Expression of cell proliferation markers in pituitary adenomas – correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIα

J. Hainfellner, T. Czech, E. Knosp, 2004, Acta Neurochirurgica.

Clinico-Pathological Study Expression of cell proliferation markers in pituitary adenomas - correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIa

J. Hainfellner, T. Czech, E. Knosp, 2004 .

Ganglionitis in paraneoplastic subacute sensory neuronopathy: A morphologic study

H. Budka, J. Hainfellner, W. Kristoferitsch, 1997, Neurology.

Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination

J. Hainfellner, I. Slavc, T. Czech, 1998, Journal of Neuro-Oncology.

Reversible occlusion shunt for intraventricular chemotherapy in shunt-dependent brain tumor patients.

J. Hainfellner, I. Slavc, T. Czech, 1997, Pediatric hematology and oncology.

A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin

M. Thurnher, J. Hainfellner, H. Lassmann, 2022, Acta Neuropathologica Communications.

Immune factors and viral interactions in brain cancer etiology and outcomes, The 2016 Brain Tumor Epidemiology Consortium Meeting report

Kimberly J. Johnson, J. Hainfellner, C. Lau, 2016, Clinical neuropathology.

Langerhans cell histiocytosis of the hypothalamus: diagnostic value of immunohistochemistry.

H. Budka, J. Hainfellner, I. Simonitsch, 1996, Clinical Neuropathology.

Lymphocytic hypophysitis presenting as a pituitary tumor in a 63-year-old man

J. Hainfellner, W. Schima, H. Vierhapper, 1995, Endocrine pathology.

αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer

M. Weller, J. Hainfellner, M. Preusser, 2014, Clinical & Experimental Metastasis.

An autosomal dominant early adult‐onset distal muscular dystrophy

J. Hainfellner, A. Djamshidian, F. Zimprich, 2000, Muscle & nerve.

Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases

H. Budka, J. Hainfellner, G. Kovacs, 2002, Acta Neuropathologica.

Toward digital histopathological assessment in surgery for central nervous system tumors using stimulated Raman histology.

C. Matula, J. Hainfellner, D. Orringer, 2022, Neurosurgical focus.

Apoplexy of a pituitary macroadenoma with reversible third, fourth and sixth cranial nerve palsies following administration of hypothalamic releasing hormones: MR features.

J. Hainfellner, W. Schima, M. Clodi, 2000, European journal of radiology.

Idiopathic inflammatory myopathies overlapping with systemic diseases

J. Hainfellner, S. Lepreux, A. Vital, 2017, Clinical neuropathology.

Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is Associated With a Novel SH2D1A Mutation

J. Hainfellner, W. Schmidt, M. Eibl, 2021, Frontiers in Immunology.

Immunohistochemical detection of class III β‐tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker

H. Budka, J. Hainfellner, M. Preusser, 2007, Histopathology.

Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.

J. Hainfellner, C. Stratakis, G. Trivellin, 2020, Human molecular genetics.

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex

Pavel Krsek, Thomas Czech, Daniela Prayer, 2016, PloS one.

Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank

J. Hainfellner, H. Haslacher, P. Hofer, 2018, Biopreservation and biobanking.

Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers

J. D. Mills, L. Lagae, I. Blumcke, 2020, Journal of neuropathology and experimental neurology.

Leukemia and the Peripheral Nervous System: A review

C. Marosi, J. Hainfellner, W. Grisold, 2014 .

Secondary gliosarcoma with massive invasion of meninges, skull base, and soft tissue, and systemic metastasis.

J. Hainfellner, A. Wöhrer, W. Grisold, 2013, Clinical neuropathology.

Naturally Occurring Herpes Simplex Encephalitis in a Domestic Rabbit (Oryctolagus cuniculus)

H. Budka, J. Hainfellner, J. Berger, 1997, Veterinary pathology.

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature

S. Weis, J. Pichler, J. Hainfellner, 2021, Journal of Neurology.

Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.

J. Hainfellner, M. Preusser, E. Knosp, 2009, Journal of neurosurgery.

Expression of hypoxia‐associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene

A. Harris, J. Hainfellner, R. Horvat, 2011, The Journal of pathology.

Anti‐O6‐Methylguanine‐Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker *

H. Heinzl, G. Reifenberger, R. Stupp, 2008, Brain pathology.

Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors

B. Kuster, S. Spiegl-Kreinecker, D. Lötsch, 2020, npj Vaccines.

Prognostic relevance of p53 protein expression in glioblastoma.

C. Marosi, H. Budka, J. Hainfellner, 2002, Oncology reports.

Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival

A. Harris, H. Budka, T. Acker, 2005, Acta Neuropathologica.

Malignant glioma: Neuropathology and Neurobiology

J. Hainfellner, M. Preusser, C. Haberler, 2006, Wiener Medizinische Wochenschrift.

Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.

Wen Shi, Matthias Preusser, Adrian L Harris, 2007, Cancer research.

Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes

Markus Bredel, Peter F Ambros, Herbert Budka, 2003, Brain pathology.

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.

M. Weller, C. Marosi, W. Wick, 2015, Neuro-oncology.

Clinical neuropathology of brain tumors.

J. Hainfellner, J. Furtner, M. Bienkowski, 2017, Handbook of clinical neurology.

Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.

J. Hainfellner, E. Knosp, A. Woehrer, 2014, Neurosurgical focus.

Diversity of cytogenetic and pathohistologic profiles in glioblastoma.

C. Marosi, D. Prayer, J. Hainfellner, 2006, Cancer genetics and cytogenetics.

αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer

M. Weller, J. Hainfellner, M. Preusser, 2014, Clinical & Experimental Metastasis.

Invasion patterns in brain metastases of solid cancers.

Frank Winkler, Julia Furtner, Matthias Preusser, 2013, Neuro-oncology.

Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.

H. Budka, J. Hainfellner, M. Preusser, 2005, American journal of clinical pathology.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

Georg Langs, Nathan C. Sheffield, Marco Augustin, 2017, Nature Medicine.

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions

H. Heinzl, C. Marosi, J. Hainfellner, 2015, Clinical neuropathology.

Response to imatinib as a function of target kinase expression in recurrent glioblastoma

C. Marosi, J. Hainfellner, M. Preusser, 2014, SpringerPlus.

Clinical neuropathology practice guide 1-2013: Molecular subtyping of glioblastoma: ready for clinical use?

J. Pichler, C. Marosi, J. Hainfellner, 2012, Clinical neuropathology.

Brain tumors - other treatment modalities.

C. Marosi, J. Hainfellner, M. Preusser, 2017, Handbook of clinical neurology.

Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO).

J. Pichler, C. Marosi, J. Hainfellner, 2013, Neuro-oncology.

Value and Limitations of Immunohistochemistry and Gene Sequencing for Detection of the IDH1-R132H Mutation in Diffuse Glioma Biopsy Specimens

J. Hainfellner, M. Preusser, B. Streubel, 2011, Journal of neuropathology and experimental neurology.

Rosette-forming glioneuronal tumor of the fourth ventricle

H. Budka, D. Prayer, J. Hainfellner, 2003, Acta Neuropathologica.

Prognostic value of Ki67 index in anaplastic oligodendroglial tumours – a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group

H. Heinzl, M. J. van den Bent, A. Brandes, 2012, Histopathology.

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers

J. Hainfellner, M. Preusser, R. Bartsch, 2016, ESMO Open.

Bioimaging and surgery of brain tumors.

J. Hainfellner, T. Czech, T. Traub-Weidinger, 2017, Handbook of clinical neurology.

University of Groningen Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex Bongaarts,

E. Aronica, J. Hainfellner, W. Grajkowska, 2020 .

Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro

J. D. Mills, E. Aronica, J. Hainfellner, 2020, Journal of neuropathology and experimental neurology.

Clinical Neuropathology Practice Guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers

H. Heinzl, J. Hainfellner, M. Preusser, 2013, Clinical neuropathology.

Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.

H. Heinzl, H. Budka, J. Hainfellner, 2006, European journal of cancer.

Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis

C. Marosi, J. Hainfellner, M. Preusser, 2012, Journal of Neuro-Oncology.

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood ( 16 years ) low grade glioma e A final report

K. Skullerud, T. Egeland, D. Machin, 2017 .

Prognostic impact of genetic alterations and methylation classes in meningioma

C. Marosi, D. Schrimpf, T. Hielscher, 2022, Brain pathology.

Patterns of diagnostic marker assessment in adult diffuse glioma: a survey of the European Confederation of Neuropathological Societies (Euro-CNS)

J. Hainfellner, B. Kristensen, A. Vital, 2016, Clinical neuropathology.

Neuropathological biomarker candidates in brain tumors: key issues for translational efficiency.

H. Heinzl, J. Hainfellner, 2010, Clinical neuropathology.

Amplification of human interneuron progenitors promotes brain tumors and neurological defects

Mercedes F. Paredes, J. Hainfellner, M. Feucht, 2022, Science.

Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions

C. Limatola, E. Aronica, J. Hainfellner, 2016, Neurobiology of Disease.

Primary central nervous system lymphoma: a clinicopathological study of 75 cases

U. Jaeger, J. Hainfellner, M. Preusser, 2010, Pathology.

AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry

David T. W. Jones, S. Pfister, A. Becker, 2013, Acta Neuropathologica.

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma

C. Marosi, J. Hainfellner, M. Preusser, 2020, Journal of Neuro-Oncology.

Immunohistochemical Analysis of Platelet-derived Growth Factor Receptor-α, -β, c-kit, c-abl, and Arg Proteins in Glioblastoma: Possible Implications for Patient Selection for Imatinib Mesylate Therapy

C. Marosi, H. Budka, J. Hainfellner, 2005, Journal of Neuro-Oncology.

Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours

C. Marosi, J. Hainfellner, M. Preusser, 2020, ESMO Open.

Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.

A. Aguzzi, J. Hainfellner, J. Theurillat, 1999, The American journal of pathology.

Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.

R. Pötter, M. Schindl, J. Hainfellner, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Incidence of atypical teratoid/rhabdoid tumors in children

H. Heinzl, J. Hainfellner, I. Slavc, 2010, Cancer.

Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma.

C. Marosi, J. Hainfellner, M. Preusser, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases

Daniela Prayer, Georg Widhalm, Karin Dieckmann, 2012, Clinical & Experimental Metastasis.

Fixation of Brain Tumor Biopsy Specimens with RCL2 Results in Well‐Preserved Histomorphology, Immunohistochemistry and Nucleic Acids

J. Hainfellner, M. Preusser, C. Mannhalter, 2010, Brain pathology.

KINFix – A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimens

J. Hainfellner, M. Preusser, C. Hartmann, 2015, Clinical neuropathology.

Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas

J. Hainfellner, T. Czech, E. Knosp, 2004, Acta Neurochirurgica.

Language network reorganization before and after temporal lobe epilepsy surgery.

G. Langs, E. Pataraia, C. Baumgartner, 2020, Journal of neurosurgery.

Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein.

C. Matula, J. Hainfellner, M. Buchfelder, 1994, The Journal of clinical endocrinology and metabolism.

Alteration of the serotonergic nervous system in fatal familial insomnia

H. Budka, S. Klöppel, J. Hainfellner, 2000, Annals of neurology.

Histopathologic assessment of hot‐spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors

Christine Haberler, Matthias Preusser, Harald Heinzl, 2006, Cancer.

Clinical Neuropathology teaching case 4-2015: Heterogenous brain pathologies temporally and spatially coinciding in limbic regions

J. Hainfellner, G. Kovacs, 2015, Clinical neuropathology.

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry

A. Olschowski, J. Pichler, C. Marosi, 2013, British Journal of Cancer.

Statistical Indicators for the Analysis of Digitalized Brain Tumor Images

Peter Filzmoser, Matthias Templ, Matthias Preusser, 2016 .

Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker

S Wolfsberger, M Preusser, H. Heinzl, 2008, Histopathology.

Evaluation of an Assay for MGMT Gene Promoter Methylation in Glioblastoma Samples

Andrew S. Kohlway, S. Spiegl-Kreinecker, J. Hainfellner, 2020, AntiCancer Research.

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography

J. Hainfellner, M. Preusser, M. Zeitlinger, 2019, EJNMMI Research.

Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach

G. Ricken, J. Hainfellner, A. Wöhrer, 2018, Clinical neuropathology.

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement

Daniela Prayer, Georg Widhalm, Barbara Kiesel, 2013, PloS one.

5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement

D. Prayer, J. Hainfellner, S. Asenbaum, 2010, Cancer.

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry

H. Heinzl, J. Hainfellner, M. Preusser, 2009, Journal of Neuro-Oncology.

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

C. Marosi, J. Hainfellner, M. Preusser, 2013, Clinical neuropathology.

Reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimens.

J. Hainfellner, M. Preusser, L. Elezi, 2008, Clinical neuropathology.

Feasibility of Long-Term Intraventricular Therapy with Mafosfamide (n = 26) and Etoposide (n = 11): Experience in 26 Children With Disseminated Malignant Brain Tumors

D. Prayer, J. Hainfellner, I. Slavc, 2003, Journal of Neuro-Oncology.

DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study

J. Hainfellner, M. Preusser, K. Roessler, 2022, Frontiers in Oncology.

Epithelial Growth Factor Receptor inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study

C. Marosi, D. Prayer, J. Hainfellner, 2008, Journal of Neuro-Oncology.

Applied Precision Cancer Medicine in Neuro-Oncology

C. Marosi, J. Hainfellner, M. Preusser, 2019, Scientific Reports.

Assessing MGMT methylation status and its current impact on treatment in glioblastoma.

C. Marosi, J. Hainfellner, M. Preusser, 2015, CNS oncology.

Teaching case 2-2020: Lhermitte-Duclos disease in a female patient with Cowden syndrome

J. Hainfellner, M. Ortler, C. Haberler, 2020, Clinical neuropathology.

Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.

J. Hainfellner, M. Preusser, T. Czech, 2017, Journal of neurosurgery.

Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies

Boguslaw Tomanek, Daniela Prayer, Georg Widhalm, 2012, Neurosurgical Review.

Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases

H. Heinzl, J. Hainfellner, M. Preusser, 2014, Strahlentherapie und Onkologie.

The physiological phosphorylation of tau is critically changed in fetal brains of individuals with Down syndrome

E. Aronica, A. Scharrer, J. Hainfellner, 2018, Neuropathology and applied neurobiology.

Angiocentric Glioma: Report of Clinico-Pathologic and Genetic Findings in 8 Cases

A. Hoischen, F. Woermann, I. Tuxhorn, 2007, The American journal of surgical pathology.

MR Fingerprinting—A Radiogenomic Marker for Diffuse Gliomas

M. Nittka, J. Hainfellner, M. Preusser, 2022, Cancers.

Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease

K. Jellinger, H. Budka, J. Hainfellner, 1998, Acta Neuropathologica.

Evidence of Therapeutic Efficacy of CCNU in Recurrent Choroid Plexus Papilloma

C. Marosi, D. Prayer, J. Hainfellner, 2000, Journal of Neuro-Oncology.

Frameless stereotactic-directed tissue sampling during surgery of suspected low-grade gliomas to avoid histological undergrading.

J. Hainfellner, C. Nasel, K. Roessler, 1998, Minimally invasive neurosurgery : MIN.

Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease

H. Budka, J. Hainfellner, G. Kovacs, 2003, Acta Neuropathologica.

Molecular diagnostics: techniques and recommendations for 1p/19q assessment.

Adelheid Woehrer, J. Hainfellner, A. Woehrer, 2015, CNS oncology.

Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex

E. Aronica, G. Ricken, J. Hainfellner, 2017, Brain pathology.

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases

J. Pichler, J. Hainfellner, M. Preusser, 2015, Neuropathology and applied neurobiology.

No prognostic impact of survivin expression in glioblastoma

C. Marosi, H. Budka, J. Hainfellner, 2005, Acta Neuropathologica.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

Nathan C. Sheffield, S. Weis, J. Pichler, 2017, bioRxiv.

FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS).

J. Hainfellner, M. Preusser, C. Hartmann, 2011, Clinical neuropathology.

OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms

H. Budka, J. Hainfellner, M. Preusser, 2007, Histopathology.

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme

C. Marosi, J. Hainfellner, C. Wenzel, 2003, British Journal of Cancer.

[Creutzfeldt-Jakob disease in a dura transplant recipient: first observation in Austria].

L. Deecke, H. Budka, J. Hainfellner, 1998, Wiener klinische Wochenschrift.

No tissue damage by chronic deep brain stimulation in Parkinson's disease

Christine Haberler, Peter Pilz, Herbert Budka, 2000, Annals of neurology.

tumor infiltrating lymphocytes in glioblastoma Running title : PD-L 1 expression in glioblastoma

M. Weller, C. Marosi, W. Wick, 2017 .

Gamma Knife Radiosurgery in Recurrent Glioblastoma

C. Marosi, J. Hainfellner, A. Ertl, 2016, Stereotactic and Functional Neurosurgery.

High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.

C. Marosi, H. Budka, M. Bredel, 2002, European journal of cancer.

Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme

C. Marosi, D. Prayer, J. Hainfellner, 2003, Anti-cancer drugs.

Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma.

J. Hainfellner, M. Preusser, C. Koelsche, 2017, Clinical neuropathology.

Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling

D. Prayer, J. Hainfellner, M. Preusser, 2019, Clinical Neuroradiology.

Microvessel density is not crucial for scintigraphic visualization of brain tumors using 99mTc-MIBI.

C. Marosi, J. Hainfellner, C. Nasel, 2004, Microvascular research.

The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma.

C. Marosi, J. Hainfellner, M. Preusser, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

DNA topoisomerase IIα predicts progression‐free and overall survival in pediatric malignant non‐brainstem gliomas

J. Zentner, I. Pollack, M. Bredel, 2002, International journal of cancer.

Glioblastoma with Spinal Seeding

C. Marosi, D. Prayer, J. Hainfellner, 2004, Strahlentherapie und Onkologie.

Algorithm for the standardized assessment of vascular patterns in glioblastoma specimens.

J. Hainfellner, M. Preusser, P. Birner, 2004, Clinical neuropathology.

Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study

C. Elger, A. Schulze-Bonhage, F. Sales, 2020, The Lancet Neurology.

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

C. Marosi, G. Ricken, J. Hainfellner, 2018, Journal of thrombosis and haemostasis : JTH.

Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma

C. Marosi, G. Ricken, J. Hainfellner, 2020, ESMO Open.

Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma

C. Marosi, J. Hainfellner, M. Preusser, 2019, Cancers.

Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study

S. Weis, J. Pichler, U. Jaeger, 2019, Acta oncologica.

Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period

J. D. Mills, L. Lagae, P. V. van Rijen, 2022, Journal of neurodevelopmental disorders.

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases

C. Bock, J. Hainfellner, M. Preusser, 2021, ESMO open.

Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients

J. Hainfellner, B. Kepplinger, H. Baran, 2012, International journal of tryptophan research : IJTR.

GABAA receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits

E. Pataraia, J. Hainfellner, W. Sieghart, 2018, The Journal of comparative neurology.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Clare C. Yu, M. N. Vidya, 2021, npj Breast Cancer.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

R. Mirimanoff, L. Mariani, R. Stupp, 2005, The New England journal of medicine.

Investigation of Adenovirus Occurrence in Pediatric Tumor Entities

T. Lion, J. Hainfellner, G. Amann, 2007, Journal of Virology.

Vitamin K2 in multiple sclerosis patients

J. Hainfellner, H. Moshammer, M. Kundi, 2018, Wiener klinische Wochenschrift.

Brain Tumor Epidemiology – A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014

Kimberly J. Johnson, B. O'neill, M. Kool, 2014, Clinical neuropathology.

Susceptibility-weighted imaging at 7 T: Improved diagnosis of cerebral cavernous malformations and associated developmental venous anomalies☆☆☆

Siegfried Trattnig, Engelbert Knosp, Johannes A. Hainfellner, 2012, NeuroImage: Clinical.

Cerebral cavernous malformations: congruency of histopathological features with the current clinical definition

J. Hainfellner, S. Trattnig, E. Knosp, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study

C. Marosi, J. Hainfellner, M. Preusser, 2014, Anti-cancer drugs.

Developmental Differences Between the Limbic and Neocortical Telencephalic Wall: An Intrasubject Slice-Matched 3 T MRI-Histological Correlative Study in Humans.

N. Jovanov-Milošević, D. Prayer, C. Mitter, 2021, Cerebral cortex.

Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature

J. Hainfellner, K. Roessler, E. Knosp, 2004, Neurosurgical Review.

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Jacqueline A. Hall, Sarah N. Dudgeon, A. Gown, 2020, npj Breast Cancer.

Advancing brain tumor epidemiology – multi-level integration and international collaboration: The 2018 Brain Tumor Epidemiology Consortium meeting report

Kimberly J. Johnson, J. Hainfellner, C. Lau, 2018, Clinical neuropathology.

Brain tumor biomarkers for research, clinics, and registries - The 2021 Brain Tumor Epidemiology Consortium meeting report.

Kimberly J. Johnson, J. Hainfellner, Q. Ostrom, 2021, Clinical Neuropathology.

Serotonergic nuclei of the raphe are not affected in human ageing

S. Klöppel, J. Hainfellner, T. Voigtländer, 2001, NeuroReport.

MicroRNA‐34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis

J. D. Mills, L. Lagae, P. V. van Rijen, 2020, Neuropathology and applied neurobiology.

Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment

J. D. Mills, L. Lagae, P. V. van Rijen, 2017, Scientific Reports.

The Digital Brain Tumour Atlas, an open histopathology resource

G. Langs, J. Hainfellner, B. Baumann, 2022, Scientific data.

Distribution of Parvalbumin‐Immunoreactive Neurons in Brain Correlates with Hippocampal and Temporal Cortical Pathology in Creutzfeldt‐Jakob Disease

H. Budka, J. Hainfellner, M. Guentchev, 1997, Journal of neuropathology and experimental neurology.

Expression of hypoxia‐inducible factor–1α in oligodendrogliomas

M. Schindl, H. Budka, J. Hainfellner, 2001 .

Thalidomide as Palliative Treatment in Patients with Advanced Secondary Glioblastoma

C. Marosi, D. Prayer, J. Hainfellner, 2014, Oncology.

Epilepsy surgery in children and adolescents with malformations of cortical development—Outcome and impact of the new ILAE classification on focal cortical dysplasia

I. Blümcke, D. Prayer, J. Hainfellner, 2014, Epilepsy Research.

Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.

D. Prayer, J. Hainfellner, M. Preusser, 2014, European journal of radiology.

Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases

J. Pichler, C. Marosi, D. Prayer, 2012, Clinical and Experimental Metastasis.

Amplification and overexpression of CMET is a common event in brain metastases of non‐small cell lung cancer

J. Hainfellner, M. Preusser, A. Deimling, 2014, Histopathology.

Analysis of the inflammatory tumor microenvironment in meningeal neoplasms.

C. Marosi, G. Ricken, J. Hainfellner, 2020, Clinical neuropathology.

Performance evaluation of the Sysmex XE-5000 hematology analyzer for white blood cell analysis in cerebrospinal fluid.

T. Szekeres, J. Hainfellner, I. Schwarzinger, 2012, Archives of pathology & laboratory medicine.

Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria

G. Ricken, J. Hainfellner, R. Desnick, 2020, Acta Neuropathologica Communications.

Evaluating cellularity and structural connectivity on whole brain slides using a custom-made digital pathology pipeline

Marco Augustin, Bernhard Baumann, Antonia Lichtenegger, 2019, Journal of Neuroscience Methods.

In vivo P-glycoprotein function before and after epilepsy surgery

S. Sisodiya, M. Koepp, E. Pataraia, 2014, Neurology.

Automated volumetry of hippocampal subfields in temporal lobe epilepsy

C. Baumgartner, R. Lanzenberger, J. Hainfellner, 2021, Epilepsy Research.

Letter in Response to David N. Louis et al, International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171

D. Louis, P. Wesseling, J. Hainfellner, 2014, Brain pathology.

Assessing prenatal white matter connectivity in commissural agenesis.

Gregor Kasprian, Daniela Prayer, Veronika Schöpf, 2013, Brain : a journal of neurology.

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center

J. Hainfellner, M. Preusser, R. Bartsch, 2018, Clinical & Experimental Metastasis.

Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult.

H. Budka, J. Hainfellner, B. Schmid-Siegel, 1993, Clinical neuropathology.

Arterial Spin-Labeling Assessment of Normalized Vascular Intratumoral Signal Intensity as a Predictor of Histologic Grade of Astrocytic Neoplasms

C. Marosi, D. Prayer, J. Hainfellner, 2014, American Journal of Neuroradiology.

Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence

G. Ricken, J. Hainfellner, M. Asslaber, 2023, Viruses.

Prenatally Diagnosed Hereditary Chondrodysplasia Punctata in The Early Second Trimester with Fetal MRI and Postmortem Correlation

D. Prayer, D. Bettelheim, A. Scharrer, 2019, Annals of Case Reports.

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

C. Marosi, G. Ricken, J. Hainfellner, 2018, Acta neuropathologica communications.

Stabilization of a Progressive Hemangioblastoma under Treatment with Thalidomide

C. Marosi, D. Prayer, J. Hainfellner, 2004, Journal of Neuro-Oncology.

Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement

Thomas Czech, Daniela Prayer, Georg Widhalm, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Association of systemic inflammation with local tumour characteristics and survival in glioma patients

C. Marosi, G. Ricken, J. Hainfellner, 2019, Annals of Oncology.

OS1.1 Plasma PD-L1 levels over time differ between glioblastoma and lower-grade glioma patients

C. Marosi, J. Hainfellner, M. Preusser, 2019, Neuro-Oncology.

Teaching Case 2-2018: Sclerosing myxopapillary ependymoma mimicking whorling-sclerosing meningioma

J. Hainfellner, I. Slavc, T. Czech, 2018, Clinical neuropathology.

125th anniversary of the Institute of Neurology (Obersteiner Institute) in Vienna. "Germ Cell" of interdisciplinary neuroscience.

H. Budka, J. Hainfellner, H. Bernheimer, 2008, Clinical Neuropathology.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

R. Mirimanoff, L. Mariani, R. Stupp, 2005, The New England journal of medicine.

K. Skullerud, T. Egeland, D. Machin, 2017, European journal of cancer.

Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?

H. Heinzl, H. Heinzl, C. Marosi, 2009, European journal of neurology.

31 Temozolomide (TMZ) targets only glioblastoma with a silenced MGMT-gene. Results of a translational companion study to EORTC 26981/NCIC CE.3 of radiotherapy ± TMZ

R. Stupp, M. Weller, U. Bogdahn, 2004 .

Primary Neuroendocrine (Merkel Cell) Carcinoma of the Anterior Skull Base

C. Matula, H. Budka, J. Hainfellner, 1997, Skull base surgery.

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

R. Mirimanoff, L. Mariani, R. Stupp, 2005 .

A simple quantitative diagnostic alternative for MGMT DNA-methylation testing on RCL2 fixed paraffin embedded tumors using restriction coupled qPCR.

J. Hainfellner, M. Preusser, M. Hofner, 2014, Clinical neuropathology.

Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis

G. Ricken, J. Hainfellner, K. Rössler, 2023, Journal of Neuro-Oncology.

Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation—A Comparative Study

J. Hainfellner, M. Preusser, S. Trattnig, 2023, Cancers.

Invasion patterns in brain metastases of solid cancers.

M. Weller, J. Hainfellner, M. Preusser, 2013, Neuro-oncology.

Rosette-forming glioneuronal tumor of the fourth ventricle

H. Budka, D. Prayer, J. Hainfellner, 2003, Acta Neuropathologica.

5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement

D. Prayer, J. Hainfellner, S. Asenbaum, 2010, Cancer.

Assessing MGMT methylation status and its current impact on treatment in glioblastoma.

C. Marosi, J. Hainfellner, M. Preusser, 2015, CNS oncology.

Kuru: Genes, Cannibals and Neuropathology

J. Hainfellner, P. Liberski, P. Brown, 2012, Journal of neuropathology and experimental neurology.

Epilepsy surgery in children and adolescents with malformations of cortical development—Outcome and impact of the new ILAE classification on focal cortical dysplasia

I. Blümcke, D. Prayer, J. Hainfellner, 2014, Epilepsy Research.

Clinical Neuropathology image 6-2018: Metastasis of breast carcinoma to meningioma

C. Matula, J. Hainfellner, E. Gelpí, 2018, Clinical neuropathology.

O6.02ANALYSIS OF PD1 AND PD-L1 EXPRESSION IN GLIOBLASTOMA

C. Marosi, W. Wick, J. Hainfellner, 2014 .

The prion protein in human neurodegenerative disorders

H. Budka, J. Hainfellner, G. Kovacs, 2002, Neuroscience Letters.